Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study

BACKGROUND: Orthotopic liver transplantation (OLT) is one of the most effective treatments for patients with hepatocellular carcinoma (HCC) within the Milan criteria. However, for patients beyond these criteria, the recurrence rate is higher and the prognosis is worse. Sorafenib is the only drug sho...

Full description

Saved in:
Bibliographic Details
Main Authors: Teng, Chieh-Lin, Hwang, Wen-Li, Chen, Yi-Ju, Chang, Kuang-Hsi, Cheng, Shao-Bin
Format: Artigo
Language:Inglês
Published: BioMed Central 2012
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3359192/
https://ncbi.nlm.nih.gov/pubmed/22339891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-10-41
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items